Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 14782 | 681 | 49.2 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | KSR1 | Author keyword | 19 | 80% | 2% | 12 |
| 2 | PEA 15 | Author keyword | 19 | 63% | 3% | 19 |
| 3 | IST ENDOCRINOL ONCOL SPERIMENTALE GAETANO SALVA | Address | 5 | 60% | 1% | 6 |
| 4 | KSR | Author keyword | 5 | 41% | 1% | 9 |
| 5 | PEA15 | Author keyword | 4 | 67% | 1% | 4 |
| 6 | KINASE SUPPRESSOR OF RAS KSR | Author keyword | 4 | 75% | 0% | 3 |
| 7 | NAT PROD CANC BIOL | Address | 4 | 75% | 0% | 3 |
| 8 | PROGRAM PHARM | Address | 4 | 44% | 1% | 7 |
| 9 | ERK2 | Author keyword | 4 | 14% | 3% | 23 |
| 10 | DOCKING INTERACTION | Author keyword | 3 | 57% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | KSR1 | 19 | 80% | 2% | 12 | Search KSR1 | Search KSR1 |
| 2 | PEA 15 | 19 | 63% | 3% | 19 | Search PEA+15 | Search PEA+15 |
| 3 | KSR | 5 | 41% | 1% | 9 | Search KSR | Search KSR |
| 4 | PEA15 | 4 | 67% | 1% | 4 | Search PEA15 | Search PEA15 |
| 5 | KINASE SUPPRESSOR OF RAS KSR | 4 | 75% | 0% | 3 | Search KINASE+SUPPRESSOR+OF+RAS+KSR | Search KINASE+SUPPRESSOR+OF+RAS+KSR |
| 6 | ERK2 | 4 | 14% | 3% | 23 | Search ERK2 | Search ERK2 |
| 7 | DOCKING INTERACTION | 3 | 57% | 1% | 4 | Search DOCKING+INTERACTION | Search DOCKING+INTERACTION |
| 8 | SEVENMAKER | 3 | 100% | 0% | 3 | Search SEVENMAKER | Search SEVENMAKER |
| 9 | MAPK PHOSPHATASES | 3 | 60% | 0% | 3 | Search MAPK+PHOSPHATASES | Search MAPK+PHOSPHATASES |
| 10 | MXI2 | 3 | 60% | 0% | 3 | Search MXI2 | Search MXI2 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PEA 15 | 38 | 71% | 4% | 30 |
| 2 | KSR 1 GENE ENCODES | 28 | 48% | 6% | 43 |
| 3 | DEATH EFFECTOR DOMAIN | 17 | 33% | 6% | 42 |
| 4 | PED PEA 15 | 17 | 63% | 2% | 17 |
| 5 | DOCKING INTERACTIONS | 14 | 39% | 4% | 29 |
| 6 | ERK MAP KINASE | 14 | 25% | 7% | 47 |
| 7 | ERK2 | 12 | 26% | 6% | 40 |
| 8 | PTP SL | 9 | 36% | 3% | 20 |
| 9 | DOCKING GROOVE | 9 | 83% | 1% | 5 |
| 10 | KSR | 8 | 52% | 2% | 11 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| ERK1/2 MAP kinases: Structure, function, and regulation | 2012 | 208 | 249 | 30% |
| The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells | 2008 | 205 | 151 | 47% |
| Coordinating ERK/MAPK signalling through scaffolds and inhibitors | 2005 | 531 | 101 | 30% |
| The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation | 2011 | 100 | 213 | 23% |
| How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer? | 2009 | 232 | 125 | 21% |
| Molecular basis of MAP kinase regulation | 2013 | 23 | 76 | 36% |
| The MEK/ERK cascade: From signaling specificity to diverse functions | 2007 | 279 | 168 | 38% |
| Differential regulation and properties of MAPKs | 2007 | 603 | 112 | 20% |
| p18/LAMTOR1: A Late Endosome/Lysosome-Specific Anchor Protein for the mTORC1/MAPK Signaling Pathway | 2014 | 3 | 15 | 40% |
| MAP kinase signalling cascades and transcriptional regulation | 2013 | 73 | 149 | 9% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IST ENDOCRINOL ONCOL SPERIMENTALE GAETANO SALVA | 5 | 60% | 0.9% | 6 |
| 2 | NAT PROD CANC BIOL | 4 | 75% | 0.4% | 3 |
| 3 | PROGRAM PHARM | 4 | 44% | 1.0% | 7 |
| 4 | DEV BIOL CANC A LACASSAGNE | 2 | 67% | 0.3% | 2 |
| 5 | U752 | 2 | 43% | 0.4% | 3 |
| 6 | SIGNALING DEV BIOL CANC | 1 | 10% | 1.9% | 13 |
| 7 | CELL DEV SIGNALING | 1 | 13% | 1.3% | 9 |
| 8 | INTRACELLULAR SIGNALING | 1 | 15% | 0.9% | 6 |
| 9 | SECT TRANSLAT BREAST CANC | 1 | 33% | 0.3% | 2 |
| 10 | ANAT BIOL CELULAR MED | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000221082 | RAF//RAF 1//LEO JENKINS CANC |
| 2 | 0.0000199337 | MKP 1//MAP KINASE PHOSPHATASE//DUAL SPECIFICITY PHOSPHATASE |
| 3 | 0.0000190049 | ERK5//MEK5//EXTRACELLULAR SIGNAL REGULATED KINASE 5 ERK5 |
| 4 | 0.0000148213 | MASS ACTION KINETICS//COMPLEX BALANCING//CHEMICAL REACTION NETWORKS |
| 5 | 0.0000128290 | JNK//MKK4//JNK3 |
| 6 | 0.0000126936 | MK2//MAPKAP K2//MK5 |
| 7 | 0.0000104272 | VRK1//VRK2//EXPT THER EUT TRANSLAT ONCOL PROGRAM |
| 8 | 0.0000098459 | COFFIN LOWRY SYNDROME//RSK2//SL0101 |
| 9 | 0.0000089046 | IQGAP1//MELUSIN//IQGAP2 |
| 10 | 0.0000085114 | SPROUTY//SPRED//SPROUTY 2 |